91. Farci P, Purcell RH. Clinical signifıcance of hepatitis C virus genotypes and quasispeices. Seminars in Liver disease 2000;20: 103-126
92. Cerny A, Chisari FY. Pathogenesis of chronic hepatitis C: lmmunological features of hepatic injury and viral persistence. Hepatology 1999;30:595601
93. Laİ ME, Mazzoleni AP, Argiolu F, et al. Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassemic children. Lancet 1994;343:388-390
94. DiBisceglie AM, Goodman DZ, Ishak KG, et al. Long-term Clinical and Histopathological Follow-up of Chronic Posttransfusion Hepatitis. Hepatology 1991;6:969-974
95. Tremolada F, Casarin C, Alberti A, et al. Long-term follow-up of non-A, non-B (typeC) posttransfusion hepatitis. J Hepatol 1992; 16:273-281
96. Mattson L, Sonnerborg A, Weiland O. Outcome of acute asymptomatic non-A, non-B hepatitis: A 13-year follow-up study of hepatitis: A 13-year follow-up study of heparitis C virus markers. Liver 1993;13:274-278
97. Koretz RL, Abbey H, Cloeman E, Gitnick G. Non-A, Non-B posttransfusion hepatitis: Looking back in the second decade. Ann Intern Med 1993; 119: 110-115
98. Keny-Walsh E, Irish Hepatology Research Group. Clinical outcomes after hepatitis C infection from contamined anti-D immunglobulin. N Eng J Med 1999;340:1228-1233
99. Power JP, Lawlor E, Davidson F, et al. Hepatitis C viremia in recipient of lrish İntravenous anti-D immunoglobulin. Lancet 1994;344:901-905
100. Gerlah JT, Marin MG, Ferrari C, et al. Natural course of symptomatic acute hepatitis C. J HepatoI1999;30:120
101. Takahashi M, Yamada G, Miyamoto R, et al. Natural eduTse of chronic hepatitis C. Am J GastroenetroI1993;88:240-245
102. Tong MJ, EI-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion associated hepatitis C. N Eng J Med 1995;332:1463-1466
62



70. SAYFAYA BENZER SAYFALAR

tabs_sener_yagiz_191898 - Sayfa
...


70. SAYFA ICERIGI

91. Farci P, Purcell RH. Clinical signifıcance of hepatitis C virus genotypes and quasispeices. Seminars in Liver disease 2000;20: 103-126
92. Cerny A, Chisari FY. Pathogenesis of chronic hepatitis C: lmmunological features of hepatic injury and viral persistence. Hepatology 1999;30:595601
93. Laİ ME, Mazzoleni AP, Argiolu F, et al. Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassemic children. Lancet 1994;343:388-390
94. DiBisceglie AM, Goodman DZ, Ishak KG, et al. Long-term Clinical and Histopathological Follow-up of Chronic Posttransfusion Hepatitis. Hepatology 1991;6:969-974
95. Tremolada F, Casarin C, Alberti A, et al. Long-term follow-up of non-A, non-B (typeC) posttransfusion hepatitis. J Hepatol 1992; 16:273-281
96. Mattson L, Sonnerborg A, Weiland O. Outcome of acute asymptomatic non-A, non-B hepatitis: A 13-year follow-up study of hepatitis: A 13-year follow-up study of heparitis C virus markers. Liver 1993;13:274-278
97. Koretz RL, Abbey H, Cloeman E, Gitnick G. Non-A, Non-B posttransfusion hepatitis: Looking back in the second decade. Ann Intern Med 1993; 119: 110-115
98. Keny-Walsh E, Irish Hepatology Research Group. Clinical outcomes after hepatitis C infection from contamined anti-D immunglobulin. N Eng J Med 1999;340:1228-1233
99. Power JP, Lawlor E, Davidson F, et al. Hepatitis C viremia in recipient of lrish İntravenous anti-D immunoglobulin. Lancet 1994;344:901-905
100. Gerlah JT, Marin MG, Ferrari C, et al. Natural course of symptomatic acute hepatitis C. J HepatoI1999;30:120
101. Takahashi M, Yamada G, Miyamoto R, et al. Natural eduTse of chronic hepatitis C. Am J GastroenetroI1993;88:240-245
102. Tong MJ, EI-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion associated hepatitis C. N Eng J Med 1995;332:1463-1466
62

İlgili Kaynaklar







single.php